Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NantHealth, Inc. | Director | Stock Option (right to buy) | 100K | Jun 9, 2022 | Direct | ||
ImmunityBio, Inc. | Director | Stock Option (right to buy) | 77.6K | Jun 11, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IBRX | ImmunityBio, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
IBRX | ImmunityBio, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
IBRX | ImmunityBio, Inc. | Jun 5, 2023 | 3 | $198K | 4 | Jun 5, 2023 | Director |
IBRX | ImmunityBio, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
NHIQ | NantHealth, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
NHIQ | NantHealth, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jul 26, 2021 | Director |
IBRX | ImmunityBio, Inc. | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |